Back to Search Start Over

PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

Authors :
Q.Y. Meng
S. Haikui
H. Shao
X.C. Ma
Source :
Value in Health. 22:S148
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Subjects

Subjects :
Insulin degludec
Oncology
medicine.medical_specialty
business.industry
Insulin glargine
Health Policy
Public Health, Environmental and Occupational Health
Basal bolus
Type 2 diabetes
medicine.disease
Term (time)
Cost utility
Internal medicine
medicine
business
medicine.drug

Details

ISSN :
10983015
Volume :
22
Database :
OpenAIRE
Journal :
Value in Health
Accession number :
edsair.doi...........a283b420398c5c172c964af05a35beb4

Tools

Authors Abstract Subjects Details